Cyclin-Dependent Kinase Modulators and Cancer Therapy

Author： Gallorini Marialucia   Cataldi Amelia   >  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.26, Iss.6, 2012-12, pp. : 377-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stromal Modulators of TGF-β in Cancer

By Costanza Brunella   Umelo Ijeoma Adaku   Bellier Justine   Castronovo Vincent   Turtoi Andrei  

Journal of Clinical Medicine, Vol. 6, Iss. 1, 2017-01 ,pp. : 7-7

MDPI

Access to resources Recommend Favorite

Biological Therapy of Breast Cancer

By Park J.W.   Tripathy D.   Campbell M.J.   Esserman L.J.  

BioDrugs, Vol. 14, Iss. 4, 2000-10 ,pp. : 221-246

Adis International

Access to resources Recommend Favorite

Targeting Mitosis for Anti-Cancer Therapy

By Sudakin Valery  

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

By Papaetis Georgios S.   Syrigos Kostas N.  

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 377-389

Adis International

Access to resources Recommend Favorite

Gene Therapy for Colorectal Cancer: Therapeutic Potential

By Chen M-J.   Chung-Faye G.A.   Searle P.F.   Young L.S.   Kerr D.J.  

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 357-367

Adis International

Access to resources Recommend Favorite